全文获取类型
收费全文 | 1020662篇 |
免费 | 78289篇 |
国内免费 | 2685篇 |
专业分类
耳鼻咽喉 | 13370篇 |
儿科学 | 35241篇 |
妇产科学 | 29036篇 |
基础医学 | 149182篇 |
口腔科学 | 28162篇 |
临床医学 | 93420篇 |
内科学 | 197734篇 |
皮肤病学 | 23421篇 |
神经病学 | 81659篇 |
特种医学 | 39306篇 |
外国民族医学 | 307篇 |
外科学 | 152105篇 |
综合类 | 23979篇 |
一般理论 | 405篇 |
预防医学 | 80197篇 |
眼科学 | 23256篇 |
药学 | 73382篇 |
3篇 | |
中国医学 | 2057篇 |
肿瘤学 | 55414篇 |
出版年
2018年 | 11163篇 |
2017年 | 8727篇 |
2016年 | 9952篇 |
2015年 | 11207篇 |
2014年 | 15181篇 |
2013年 | 23081篇 |
2012年 | 30637篇 |
2011年 | 32383篇 |
2010年 | 19433篇 |
2009年 | 18295篇 |
2008年 | 30125篇 |
2007年 | 31948篇 |
2006年 | 32425篇 |
2005年 | 31004篇 |
2004年 | 30227篇 |
2003年 | 28943篇 |
2002年 | 27997篇 |
2001年 | 47294篇 |
2000年 | 48294篇 |
1999年 | 40542篇 |
1998年 | 11455篇 |
1997年 | 10305篇 |
1996年 | 10371篇 |
1995年 | 9945篇 |
1994年 | 9238篇 |
1993年 | 8610篇 |
1992年 | 32396篇 |
1991年 | 31625篇 |
1990年 | 31151篇 |
1989年 | 30039篇 |
1988年 | 27325篇 |
1987年 | 27449篇 |
1986年 | 25535篇 |
1985年 | 24717篇 |
1984年 | 18517篇 |
1983年 | 15604篇 |
1982年 | 9377篇 |
1981年 | 8477篇 |
1979年 | 16962篇 |
1978年 | 12297篇 |
1977年 | 10403篇 |
1976年 | 9838篇 |
1975年 | 10257篇 |
1974年 | 12400篇 |
1973年 | 11920篇 |
1972年 | 10965篇 |
1971年 | 10169篇 |
1970年 | 9429篇 |
1969年 | 8782篇 |
1968年 | 8133篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
11.
Anne-Sophie Worm Fenger Markus Harboe Olsen Maria Louise Fabritius Christian Gunge Riberholt Kirsten Møller 《Acta anaesthesiologica Scandinavica》2023,67(2):240-247
Background
Hyperglycaemia is common in patients with acute brain injury admitted to an intensive care unit (ICU). Many studies have found associations between development of hyperglycaemia and increased mortality in hospitalised patients. However, the optimal target for blood glucose control is unknown. We want to conduct a systematic review with meta-analysis and trial sequential analysis to explore the beneficial and harmful effects of restrictive versus liberal glucose control on patient outcomes in adults with severe acute brain injury.Methods
We will systematically search medical databases including CENTRAL, Embase, MEDLINE and trial registries. We will search the following websites for ongoing or unpublished trials: http://www.controlled-trials.com/ , http://www.clinicaltrials.gov/ , www.eudraCT.com , http://centerwatch.com/ , The Cochrane Library's CENTRAL, PubMed, EMBASE, Science Citation Index Expanded and CINAHL. Two authors will independently review and select trials and extract data. We will include randomised trials comparing levels of glucose control in our analyses and observational studies will be included to address potential harms. The primary outcomes are defined as all-cause mortality, functional outcome and health-related quality of life. Secondary outcomes include serious adverse events including hypoglycaemia, length of ICU stay and duration of mechanical ventilation, and explorative outcomes including intracranial pressure and infection. Trial Sequential Analysis will be used to investigate the risk of type I error due to repetitive testing and to further explore imprecision. Quality of trials will be evaluated using the Cochrane Risk of Bias tool, and quality of evidence will be assessed using the Grading of Recommendations, Assessment, Development and Evaluations (GRADE) approach.Discussion
The results of the systematic review will be disseminated through peer-reviewed publication. With the review, we hope to inform future randomised clinical trials and improve clinical practice. 相似文献12.
Marike Gabrielson Mattias Hammarström Magnus Bäcklund Jenny Bergqvist Kristina Lång Ann H Rosendahl Signe Borgquist Roxanna Hellgren Kamila Czene Per Hall 《International journal of cancer. Journal international du cancer》2023,152(11):2362-2372
Tamoxifen prevents recurrence of breast cancer and is suggested for preventive risk-reducing therapy. Tamoxifen reduces mammographic density, a proxy for therapy response, but little is known about its effects in remodelling normal breast tissue. Our study, a substudy within the double-blinded dose-determination trial KARISMA, investigated tamoxifen-specific changes in breast tissue composition and histological markers in healthy women. We included 83 healthy women randomised to 6 months daily intake of 20, 10, 5, 2.5, 1 mg of tamoxifen or placebo. The groups were combined to “no dose” (0-1 mg), “low-dose” (2.5-5 mg) or “high-dose” (10-20 mg) of tamoxifen. Ultrasound-guided biopsies were collected before and after tamoxifen exposure. In each biopsy, epithelial, stromal and adipose tissues was quantified, and expression of epithelial and stromal Ki67, oestrogen receptor (ER) and progesterone receptor (PR) analysed. Mammographic density using STRATUS was measured at baseline and end-of-tamoxifen-exposure. We found that different doses of tamoxifen reduced mammographic density and glandular-epithelial area in premenopausal women and associated with reduced epithelium and increased adipose tissue. High-dose tamoxifen also decreased epithelial ER and PR expressions in premenopausal women. Premenopausal women with the greatest reduction in proliferation also had the greatest epithelial reduction. In postmenopausal women, high-dose tamoxifen decreased the epithelial area with no measurable density decrease. Tamoxifen at both low and high doses influences breast tissue composition and expression of histological markers in the normal breast. Our findings connect epithelial proliferation with tissue remodelling in premenopausal women and provide novel insights to understanding biological mechanisms of primary prevention with tamoxifen. 相似文献
13.
14.
15.
Louise Danielsson RPT MSc Susanne Rosberg RPT PhD 《Scandinavian journal of caring sciences》2015,29(3):501-509
Although depression is associated to physical discomfort, meanings of the body in depression are rarely addressed in clinical research. Drawing on the concept of the lived body, this study explores depression as an embodied phenomenon. Using a hermeneutic phenomenological approach, the analysis of narrative‐based interviews with 11 depressed adults discloses a thematic structure of an embodied process of an ambiguous striving against fading. Five subthemes elicit different dimensions of this process, interpreted as disabling or enabling: feeling estranged, feeling confined, feeling burdensome, sensing life and seeking belongingness. In relation to clinical practice, we suggest that the interdisciplinary team can focus on enhancing the enabling dimensions, for example through guided physical activities to support the patient to feel more alive, capable and connected. Moreover, we suggest that the treatment process benefits from an increased awareness of the ambiguity in the patient's struggle, acknowledging both destructive and recharging elements of the withdrawing, and the perceived conflict in‐between. 相似文献
16.
17.
18.
19.
20.
Alexandra B. Morshed Rachel G. Tabak Cynthia D. Schwarz Debra Haire-Joshu 《Journal of nutrition education and behavior》2019,51(2):237-244